Intravenous Medication Administration Errors in Hospitalised Patients: An Updated Systematic Review.

Background: Administering intravenous (IV) drugs carries a high risk of adverse effects due to their direct entry into circulation. Identifying the prevalence and types of IV administration errors and the drugs involved is crucial for implementing effective interventions to reduce such errors.

Aim: This systematic review aimed to examine and synthesise the available articles on medication errors involving IV administration in hospitalised patients.

antimicrobial resistant pattern, plasmid profile and the survival of isolated from poultry sources.

1. Infections due to spp. significantly contribute to bacterial gastroenteritis worldwide.

Reduced allergenicity of hydrolysed whey protein concentrate complexed with iron: the effect of different enzymes, degree of hydrolysis and ascorbic acid.

Unlabelled: Cow's milk allergy is a hypersensitivity reaction to bovine milk proteins and is immune-related. β-lactoglobulin, the primary allergenic protein found in milk, is a whey protein with a higher biological value than casein. The study aimed to develop a hypoallergenic fortified supplement, with hydrolysed whey proteins as a channel for iron fortification.

Physico-chemical characterization and fuzzy logic sensory evaluation of : a dairy product of Kerala.

Unlabelled: The food culture of India is very diverse and has evolved over thousands of years, with each region of the country having its unique cuisine. is a popular buttermilk-based vegetable preparation from the south Indian state Kerala. Many traditional food knowledge (TFK) are associated with this product and the ingredients used in its preparation deliver various functional properties.

Functional and molecular single-cell analyses implicate PRDM14 in the initiation of B cell leukemia in mice.

The transcription factor Prdm14 is a potent oncogene implicated in the initiation of many cancers. PRDM14 resets and maintains the pluripotent state in normal cells, but the molecular mechanisms through which PRDM14 drives oncogenesis are poorly understood. Here, we interrogated the heterogeneity of Prdm14-expressing cells in a T cell lymphoblastic leukemia/lymphoma mouse model.